A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer
Titel:
A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer
Auteur:
Blumenschein Jr, G.R. Kabbinavar, F. Menon, H. Mok, T.S.K. Stephenson, J. Beck, J.T. Lakshmaiah, K. Reckamp, K. Hei, Y.-J. Kracht, K. Sun, Y.-N. Sikorski, R. Schwartzberg, L.